Rising Star: A role for miRNA-21 in non-alcoholic fatty liver disease (NAFLD) pathogenesis / Genetic risk stratification of NAFLD in clinical care: Where do we stand today?

Pedro M. Rodrigues  ¹     Salvatore Petta  ^2    
1 Biodonostia Health Research Institute
² University of Palermo Italy 48.37

Topic
Disease Mechanisms, Gut Microbiota, Hepatobiliary, Immunology, Pancreas

Session
Where basic scientists meet clinicians: Mechanisms of injury and implications for the clinician

Conference
UEG Week 2022